Abstract:
Two groups of  200  broilers,  strain  ISA15,  have  been raised  in  the  same  building  with  the  same ambient  conditions,  lighting,  and  feeding,  during  two  periods,  the  first,  in  spring  time  (April- May). ) and the second in the autumn period (October-November).broilers received three vitamin treatments  in  the  drinking  water  (chicktonic  premix,  vitE  /  selenium  and  antistress,  betamint)from 1day to 48 day. In order to avoid cases of rickets or growth retardation, as well as breeding stress , all chickens in the summer treated with chicktonic as miltivitamin and betamint. The lots were identified according to the following therapeutic schema: control lot CH (chicktonic 1ml /, betamint 1ml / then 2ml / l from day 41). Lot CH + 41 (chicktonic 1ml / l then 2.5 ml / l from day 41, betamint, same as controllot ). Lot CH + 13 (chicktonic 1ml / l, then increasing the dose gradually from day 13). Lot VitE / Se + 41 (1ml / l then 2.5 ml / l from day 41, betamint, same as controllot ). Lot VitE / Se + 13 (1ml / l, then increase the dose gradually from day 13). Lot Bet + 13: chicktonic 1ml / l, betamint 1ml / l, then increase the dose gradually from day 13). The results obtained are significant at the p< 0.05, for live weight, yields, and blood profile. We obtained the best live weight (2821.33  g ± 229.77) with the increase in the dose of vitamin E / Selenium  from  day  41.  Increased  doses  of  chicktonic  from  day  41  improved  performance,  IC (2.08 ± 1.0) and IP (358.24 ± 313.25) and CV% (8.3), as well as serum cholesterol (1.23 g / l ± 0.17) and blood glucose (2.34 g / l ± 0.21), but carcass yield (74.70% ± 4.99) and that of organs are better when the doses were increased from day 13.  Increasing the selvite dose from day 13 gave a lower IC (1.6 ± 1.6). The organ yield is better with the lowest abdominal fat yield (0.69 ± 0.28). The increase in dose of antistressBetamint, gave a high level of total protein (34.50 g / l ± 4.63), that of cholesterol (1.32 g / l ± 0.17) and that white blood cells (952.2610 ^ 3 / μl ± 26.60).
With  respect  to  the  mortality  rate,  the  three  treatments  gave  low  values between  0.10%  and 0.33%.